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Abstract
Buddleja cordata is a species used by Mexican folk medicine for treating illnesses related to inflammation such as skin wounds
and arthritis. It bio-synthesizes metabolites such as verbascoside that contributes to its ethno-therapeutic properties as anti-
inflammatory remedy. HPLC analysis showed that the methanolic extract from cell suspension cultures (Bc-Cc) and wild plant
leaves (Bc-Wp) contained verbascoside, but concentration was higher in Bc-Cc (87.48 mg/g) than in wild plant (47.34 mg/g).
In the acute toxicity model, none of the extracts generated any lethality or adverse effects. In acute inflammation model induced
with TPA, Bc-Cc extract showed a greater edema inhibition at 2 mg/ear (61.72%), as well for carrageenan model at 200 mg/kg
(48.87%). Bc-Wp showed lesser anti-inflammatory effect in both acute inflammation models than Bc-Cc. For Adjuvant-induced
arthritis both extracts at 250 mg/kg generated a moderate inhibition over edema (≈ 33%) at day 28, and they were statistically no
different to phenilbutazone. The culture in suspension of B. cordata obtained by biotechnological process contains greater amount
of verbascosido and showed better anti-inflammatory activity; thus, representing a source for obtaining this type of secondary
metabolite of pharmacological interest.
Keywords: cell suspension culture, Buddleja cordata, verbascoside, anti-inflammatory activity, median lethal dose.
Resumen
Buddleja cordata es una planta medicinal usada en Me´xico para el tratamiento de enfermedades relacionadas con heridas en
la piel y artritis. Esta especie bio-sintetiza metabolitos secundarios como el verbasco´sido, el cual contribuye a sus propiedades
etno-medicinales. El ana´lisis por HPLC mostro´ que el extracto metano´lico del cultivo en suspensio´n celular (Bc-Cc) y de las
hojas de la planta silvestre (Bc-Wp) contienen verbasco´sido, siendo su concentracio´n mayor en el cultivo Bc-Cc (87.48 mg/g)
que en la planta silvestre (47.34 mg/g). Ninguno de los extractos genero´ letalidad o efectos adversos en el ensayo de toxicidad
aguda. En el modelo de inflamacio´n to´pica inducido con TPA, Bc-Cc mostro´ mayor actividad antiinflamatoria; a 2 mg/oreja
genero´ 61.72% de inhibicio´n y en el modelo de carragenina a 200 mg/kg genero´ 48.87%, mientras que Bc-Wp mostro´ menor
actividad anti-inflamatoria en ambos modelos. En el modelo de artritis inducida con Adyuvante de Freud completo, ambos
extractos a 250 mg/kg mostraron moderada actividad anti-inflamatoria, con inhibicio´n de aprox. 33% al dı´a 28. El cultivo en
suspensio´n celular de B. cordata obtenido por proceso biotecnolo´gico contiene mayor cantidad de verbascosido y mostro´ mejor
actividad anti-inflamatoria; por lo que representa una fuente para la obtencio´n de este tipo de metabolito secundario de intere´s
farmacolo´gico.
Palabras clave: cultivos de suspensio´n celular, Buddleja cordata, verbasco´sido, actividad anti-inflamatoria, dosis letal media.
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1 Introduction
During last two decades, study to support the ethno-
medicinal use of plants as traditional remedies has
increased. From this research, a growing number of
new drugs have been developed through synthesis
or semi-synthesis, employing, as structural prototype,
Secondary Metabolites (SM) isolated from medicinal
plants (Dakah et al., 2014).
In addition, novel investigation lines using
biotechnology techniques have been established to
develop in vitro cultures capable of producing
SM, as well as to evaluate their pharmacological
potential with a higher yield rate (Singh et al.,
2009). In this context, there is great interest
in discovering new drugs possessing beneficial
pharmacological activities such as anti-inflammatory
that those showed by commercialized allopathic
drugs which have demonstrated significant secondary
adverse side effects (Martı´nez-Va´zquez et al., 1998;
Pe´rez-Herna´ndez et al., 2014).
Buddleja cordata Humb. Bonpl. & Kunth,
commonly known as Tepoza´n blanco, has been
used diversely in Mexican traditional medicine as a
treatment for several health disorders, such as tumors,
abscesses, sores, burn wounds, rheumatic pains, skin
illness and inflammation related to arthritis. Today,
these ethno-medicinal uses require support from
scientific studies (A´vila-Acevedo et al., 2014).
Anti-inflammatory activity of some Buddleja
species (Jensen, 2000; Pendota et al., 2013, Pendota
et al., 2014) has been previously described; this
biological activity was tested in preclinical murine
models of acute inflammation induced by Carrageenan
and skin wounds induced by surgical injury. The
results showed that the aqueous and methanolic
(MeOH) extracts obtained from whole wild plants
(Wp) of B. globosa (Backhouse et al., 2008), B. crispa
(Bukhari et al., 2016), and B. polystachia (Al-Ati
et al., 2015) showed an important inhibitory effect.
The inhibition was between 65 and 71%, on sub-
plantar edema growth induced by Carrageenan in rats
at doses of 50, 100, and 500 mg/kg administered
by intraperitoneal (i.p.) route, as well as at doses of
300 and 600 mg/kg by intragastric (i.g.) route have a
similar anti-inflammatory effect.
Additionally, aqueous extract from B. cordata
exhibited anti-inflammatory activity on Carrageenan-
induced edema in male Wistar rats at 10, 50, and 100
mg/kg when was administered via i.g. route, with an
inhibitory effect on paw-edema development of 34.3,
42.4, and 50.5%, respectively (Martı´nez-Va´zquez et
al., 1998).
The SM produced by B. cordata, terpenoid- and
phenolic-type, have been related with its medicinal
uses, such as aucubin and methylcatalpol iridoids,
sesquiterpenes, sitosterol steroids, linarin, flavones,
hydroxycinnamic acids and verbascoside (Vb), with
the knowledge that these SM have been reported
as anti-inflammatory agents (Akdemir et al., 2011;
Jensen, 2000; Martı´nez-Va´zquez et al., 1998; Sa´nchez
et al., 2013).
The in vitro cell suspension cultures obtained from
roots, callus and leaves tissues of B. cordata produced
linarin, some hydroxycinnamic acids (caffeic, p-
coumaric, ferulic, and sinapic acids) and Vb, in higher
concentration than Wp. The production of these SM
depended on the type of in vitro cell culture; these
in vitro cultures produced a high amount of Vb
116.36 mg/g dried weight (DW), while the contents
of linarin and hydroxycinnamic acid were <3.01 mg/g
DW (Estrada-Zu´n˜iga et al., 2009). This is the first
study that compares and quantifies the content of
verbascoside between a wild plant and a sample of
material produced by a biotechnological process (Wp
vs. Cc). In addition, it is the first report that describes
the comparison of the anti-inflammatory activity of
Bc-Wp vs. and Bc-Cc.
To date there are no published reports related to the
anti-inflammatory activity of extracts obtained from
cell suspension cultures either of B. cordata or for the
leaves of Wp in murine models of acute and chronic
inflammation. The aim of this work was to evaluate
the anti-inflammatory activity of MeOH extracts from
Wp leaves and cell suspension cultures of B. cordata
for comparison in order to evaluate the potential of
a cell culture to produce anti-inflammatory bioactive
metabolites, to determine their acute toxicity in vivo,
and compare the concentration of their major SM by
in vitro and HPLC techniques.
2 Materials and methods
2.1 Plant materials
Leaves from approximately 2-year-old plants
were collected from Santa Marı´a Village in
Apaxco, State of Mexico, Mexico, in January
2017. A sample was deposited at the Universidad
Auto´noma Metropolitana-Iztapalapa Campus (UAM-
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I) Herbarium, identified as Buddleja cordata Kunth
(Buddlejaceae), and was registered with specimen
number 61170. Dried biomass from the cell culture
of B. cordata was provided by the Centro de
Investigacio´n en Recursos Bio´ticos (CIRB)-Facultad
de Ciencias de la Universidad Auto´noma del Estado
de Me´xico (UAEMex) and the UAM-I Biotechnology
Laboratory. The cell culture has been previously
established by Estrada-Zu´n˜iga et al. (2009). Cells
from culture were collected every 15 days after sub-
cultivation due to this was established as the time in
which B. cordata cell suspension reach its maximum
production of verbascoside in liquid medium.
2.2 Preparation of extracts
Wild B. cordata leaves (250 g) were dried at room
temperature and then were macerated with MeOH (5
L) for 2 weeks with constant shaking (three times).
The MeOH extract was filtered and concentrated
at 40°C using a rotary evaporator (Buchii RE-111)
coupled to a vacuum system (BuchiiVacV-153) and
a cooling system (ECO20). The Bc-Wp extract was
maintained under conditions of darkness until its use.
Dried biomass from cell suspension cultures (50 g)
was macerated in MeOH (3 L) to obtain the final
extract (Bc-Cc). Elaboration of the MeOH extract was
the same as that described previously for wild plant.
2.3 High Performance Liquid Chromatography
(HPLC) analysis
Prior to use, each MeOH extract and standard solution
was filtered (0.45 µm, nylon filter) for HPLC analysis
as described by Estrada-Zu´n˜iga et al. (2009; 2016).
Waters HPLC system with 717 plus Autosampler,
1525 Binary Pump (Waters, USA), 2847 Dual λ
Absorbance Detector (Waters, USA) equipped with
a Kromasil C18 column (250 mm x 4.6 mm, 5
µm; Supelco, Sigma Chemical Co., USA) was used.
Mobile phase: 2% (v/v) acetic acid solution (solvent
A) and acetonitrile (solvent B); a sample injection
volume of 10 µL (samples of 1,500 µg/mL), a flow
rate of 1.1 mL/min, and a wavelength of 330 nm
for the detector. The system was run with a gradient
program as follows: 2 min, 100% to 88% A; 5
min, 88% to 75% A; 5 min, 75% to 0% A, and
3 min, 0% to 100% A. Stock standard solutions
(0.22 mg/mL) of Vb (Extrasynthese, France) were
prepared to obtain the calibration curve (40, 75,
120, and 220 mg/mL; y = 13570x − 361269; R2 =
0.9947). Standard and MeOH extracts were run in
the same condition. CHEMSTATION chromatography
software (Rev. A.08.03; Agilent Technologies) was
utilized to acquire data from the detector. For
detecting, identifying, and quantifying verbascoside
(main metabolite) from samples, peak areas at the
corresponding standard Retention time (Rt) were
employed to determine their concentration from the
prepared calibration curve. Each sample was injected
three times (n = 3).
2.4 in vitro techniques
2.4.1 Total phenolic content (TPC)
This assay was determined using the Folin-Ciocalteu
reagent with the method previously described by
McDonald et al. (2001). Each experiment was carried
out by triplicate at 800 µg/mL for each MeOH extract,
absorbance results were interpolated on a standard
curve using gallic acid as reference (range, 150 -
2,500 µg/mL), in the equation y = 0.0227x + 0.1736,
where “y” is the absorbance values obtained from each
sample and “x” is the value of the µg of gallic acid
equivalents (GAE)/g of dried extract (R2 = 0.9927).
2.4.2 Total flavonoid content (TFC)
The aluminum chloride colorimetric method used for
flavonoid determination was described by Chang et al.
(2002). Each experiment was carried out by triplicate
at 2,400 µg/mL for each MeOH extract, while the
absorbance results were interpolated on a standard
curve using quercetin as reference (range, 150 - 2,500
µg/mL) in the equation y = 0.001x+0.0759, where “y”
is the absorbance value obtained from each sample and
“x” is the value of µg of quercetin equivalents (QE)/g
of the dried extract (R2 = 0.9969).
2.5 In vivo animal assays
Adult Balb/C mice (25 ± 2 g) of both sexes
were used for the preclinical acute toxicity and
acute/chronic inflammation models. The mice were
obtained from the Animal Vivarium of CMN-SXXI,
IMSS, in Mexico City and were maintained in plastic
cages during a 7-day conditioning period prior to
the experiments under laboratory conditions (12h/12h
light/dark cycles; temperature, 25 ± 2°C; humidity 55-
80%) with Rodent Chow food and water ad libitum.
Experiments were performed following the statutes of
the International Committee for the Care and Use of
Laboratory Animals (IACUC) and of Mexican Official
Norm (NOM-062-ZOO-1999), revised in 2017.
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2.5.1 Acute toxicity
This test was performed according to Procedure
TG423 described by the OECD and Test Guidelines
as described by Gutie´rrez-Rebolledo et al. (2016).
Groups of three animals (n = 3) were employed and
the MeOH extracts of the Bc-Wp and Bc-Cc were
administered by i.g. route after a fasting period of
12 h. Control received only the vehicle (Tween 80-
:water, 1:9), and the treated groups received a single
administration of MeOH extract at 2, 1, and 0.5 g/kg
Body Weight (BW) doses, in a volume not exceeding
10 mL/kg BW. The animals were maintained under
observation for 14 days and their BW gain was
recorded on days 3, 7, 9, and 14. After that, animals
were euthanized, and liver, stomach, spleen, and both
kidneys were extracted, and macroscopic observation
was conducted to find gross pathological lesions
and relative weight changes. This experiment was
performed in two independent tests for each group to
establish the median lethal dose (LD50), according to
the parameters described by the Globally Harmonized
Classification System for Chemical Substances and
Mixtures categories in which this value is established
as a range of doses related to lethality and toxicity
signs in the laboratory animals: Category 1 (> 0 - 5
mg/kg), Category 2 (> 5 - 50 mg/kg), Category 3 (>
50 - 300 mg/kg), Category 4 (> 300 - 2000 mg/kg) and
Category 5 (> 2000 - 5000 mg/kg), being 2000 mg/kg
the dose limit admitted for this kind of preclinical
studies.
2.5.2 12-O-tetradecanoylphorbol-13-Acetate (TPA)-
induced ear edema
This assay was conducted as described by Gutierrez-
Rebolledo et al. (2016). Control was treated with TPA
(2.5 µg) in acetone on the right ear (Ws) and then
the left ear received only 25 µL of acetone (Wo).
The experimental groups (n = 7) received TPA and
30 min later, both MeOH extracts, or Indomethacin
(0.5, 1, and 2 mg/ear), were applied into the right
ear (Ws′), while their left ear received only 25 µL of
acetone (Wo′). Treatments 1 (Bc-Cc) and 2 (Bc-Wp),
were carried out in independent experiments with their
respective controls. Anti-inflammatory activity was
calculated according to the weight difference (mg)
between the ear sections (6 mm) at 6 h, compared to
control group, using the following formula:
%Inhibition =
[
(Ws−Wo)TPA control− (Ws′ −Wo′)TPA treated
(Ws′ −Wo′)TPA control
]
× 100 (1)
2.5.3 Carrageenan-induced sub-plantar edema in
mice
This model was performed as described by Gutie´rrez-
Rebolledo et al. (2016). Treated groups (n = 7)
received, by i.g. route, Indomethacin (10 mg/kg),
and both MeOH extracts (10, 25, 50, 100, and 200
mg/kg) 1 h prior to Carrageenan injection (20 µl, 2%).
Treatments were solubilized in Tween 80:water (1:9),
and the control received vehicle alone; all animals
were administered in a volume not exceeding 10
mL/kg BW. Treatments 1 (Bc-Cc) and 2 (Bc-Wp)
were carried out in independent experiments with
their respective controls. Percentage of inhibition was
calculated by comparing the measurement of paw
edema at different times (1, 2, 3, 5, and 7 h) (Et),
using a digital micrometer and the value of time zero
(baseline) (E0) was determined in mm. The results
were analyzed with the following formula:
%Inhibition =
[
(Et− E0)Carrageenan control− (Et− E0)Carrageenan treated
(Et− E0)Carrageenan control
]
× 100 (2)
2.5.4 Median Effective Dose (ED50)
ED50 was determined by means of the data obtained
from the previously above described experiments and
their dose-response curves for TPA and Carrageenan
(Gutie´rrez-Rebolledo et al., 2016; Perazzo et al.,
2013). This method was employed to evaluate the
effectiveness of the MeOH extracts of B. cordata in
relation to the inhibition of the inflammatory process
by comparison with the Indomethacin groups.
2.5.5 Complete Freund’s Adjuvant (CFA)-induced
arthritis
This model was carried out according to Rasool et
al. (2006), with modifications. All groups (n = 7)
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were injected subcutaneously (s.c.) with 25 µL of
CFA in the right hind paw on days zero and 14
(reinjection). Treatment groups were administered by
i.g. route with phenilbutazone (PBZ, 100 mg/kg,
reference drug), and the MeOH extracts of the Bc-
Cc and Bc-Wp samples [250 mg/kg (ED50 value from
acute inflammation induced by Carrageenan)], daily
from day 7 to 27. A group of mice was not injected
with CFA and was administered by i.g. route with
vehicle only to obtain healthy animals. All treatments
were solubilized in Tween 80:water (1:9), healthy-
animal group and arthritic animals without treatment
received vehicle alone. Paw edema was measured at
different times (1, 4, 7, 14, 15, 21, and 28 days) (Et)
using a digital micrometer (Mitutoyo model 293-831)
and a value of day zero (E0) was determined in mm.
Edema percentage of inhibition in each group was
calculated from day 14 to day 28 and was compared
with that of CFA group without treatment as follows:
%Inhibition =
[
(Et− E0)CFA control− (Et− E0)CFA treated
(Et− E0)CFA control
]
× 100 (3)
BW gain was also registered on the same days. BW
gain was calculated using each weight measurement
at different times (1, 4, 7, 14, 15, 21, and 28 days)
compared to baseline weight (day zero) prior to CFA
injection. Then the differences (g) were employed to
make a graph. Finally, on day 28 of the experiment,
the mice were euthanized, and the edema tissue and
popliteal ganglion nearest to the edema were extracted
to calculate their relative weight. Relative weight (%)
was calculated utilizing the total weight of both tissues
(g) related to the total BW of the mice on day 28.
2.6 Statistical analysis
NCSS software was utilized for statistical analyses
of the percentage of callus- or root-induced
response, growth parameters, and phenylpropanoid
concentration. One-way analysis of variance
(ANOVA) followed by Tukey-Kramer multiple-
media comparison tests were executed. A p value
of <0.05 was assumed for significant differences.
All of the experiments and measurements were done
by triplicate. Sigma Plot ver.12.0 statistical software
(2011-2012) was utilized for the analysis of the results.
Data was presented as standard error of the mean
(SEM). BW gain values in the acute toxicity test, BW
gain and paw edema development during experimental
arthritis were analyzed with bifactorial ANOVA, with
a post-hoc Student-Newman-Keuls (SNK) test. On
the other hand, organ relative weight was evaluated
through ANOVA on ranks test, with a post-hoc SNK.
Finally, for the development of paw edema in the
Carrageenan model and ear-edema weight in TPA,
one-way ANOVA was employed with a post-hoc SNK
test. Results of p <0.05 were considered statistically
significant.
3 Results and discussion
3.1 Phenolic compound quantification:
Verbascoside, and total phenol and
flavonoid content
The chemical profile of a medicinal plant is directly
related to its traditional uses, biological activities,
and pharmacological properties. In this context, the
ethno-medicinal properties, such as anti-inflammatory,
could be attributed to some SM bio-synthetized
by B. cordata, such as Vb. Bc-Cc showed a Vb
concentration of 20.48 ± 1.84 mg/g extract DW,
while Bc-Wp exhibited 6.20 ± 0.77 mg/g extract DW.
Additionally, the yield of resulting MeOH extracts was
43.26 and 7.06% (g of extract/g initial biomass DW),
respectively. By HPLC analysis, it was demonstrated
that the cell culture has the capacity to produce
a greater amount of Vb than Wp (Figure 1A and
1B), and these results were related to total Vb
concentration, which was higher for Bc-Cc (87.88
±5.14 mg/g initial biomass DW) than for Bc-Wp
(47.34 ±2.66 mg/g initial biomass DW). On the other
hand, TPC test demonstrated that Bc-Wp had a greater
amount of these compounds (45.47 ± 0.04 mg GAE/g
DW of extract) than Bc-Cc extract (3.85 ± 0.01 mg
GAE/g extract DW). This same behavior was observed
for TFC test in which Bc-Wp exhibited higher values
(937.85 ± 0.02 µg QE/g extract DW) compared to
Bc-Cc results (20.35 ± 0.01 µg QE/g extract DW).
These results revealed that, unless the leaves from
Wp produced higher concentrations of SM, such as
polyphenols and flavonoids than cell culture, this last
one could bio-synthesize to nearly double the amount
of Vb than Wp leaves, and at a high purity level which
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Fig. 1. HPLC Chromatograms of MeOH extracts from Wild plant B. cordata leaves (Bc-Wp) and its Cell suspension
culture (Bc-Cc). A) Chromatogram of MeOH extract from Wild plant B. cordata leaves (Bc-Wp). B) Chromatogram
of MeOH extract from B. cordata Cell suspension culture (Bc-Cc). C) Vb standard with Rt = 11.6 min.
could be obtained and isolated in MeOH extract, as
illustrated in HPLC chromatograms (Figs. 1A and 1B).
From which is described previously, it appears
that Bc-Cc underwent a decrease in both phenolic
and flavonoid content compared to Bc-Wp. These
results match those found by Estrada-Zu´n˜iga et al.
(2016), in which the authors compared TPC of
MeOH extracts from Wp B. cordata aerial parts,
greenhouse-cultivated plants, and micropropagated
plantlets obtained biotechnologically in vitro. The
results demonstrated that greenhouse plants exhibited
values of 84.2 mg GAE/g, followed by Wp with 36.6
mg GAE/g, and finally, micropropagated plantlets 24.8
mg GAE/g of dried extract. The authors adjudicated
these results to the decrease in TPC data and also
a low antioxidant capacity, in terms of the different
conditions under which each plant material was grew,
such as environmental conditions and interactions,
due to phenolic compounds are SM that the plant
synthesized as a response to an external stimulus,
such as an attack by microorganisms and nutrient
competition with other plant species, which change
their biochemical and physiological processes.
3.2 Acute toxicity
None of the tested doses (2, 1, and 0.5 g/kg) of Bc-
Wp and Bc-Cc generated lethality or adverse effects
on BW gain (data not shown), as well neither of both
extracts modified behavior in mice during the 14-day
observation period after a single i.g. administration.
No macroscopic alterations were observed either in the
main analyzed organs after euthanasia or in differences
in the relative weights of these major organs among the
groups (data not shown).
Although in vitro culture of cells obtained from
medicinal plants is a line of investigation that is
under constant development, to date there are scarce
studies that evaluate toxicity of these cell suspensions
and extracts made from them. In addition, there are
few papers in which a biological activity in vivo of
these cell suspensions extracts is tested (Pramanik and
Chatterjee, 2009). Such studies are needed because,
through biotechnological process, SM concentrations
increase in plant tissues or in cell suspensions and
these could generate toxic effects in vivo. As an
example, LD50 value of MeOH extract from cell
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suspension cultures obtained from leaves of Pluchea
indica was 2.825 g/kg when administered i.g. in rats
(Pramanik and Chatterjee, 2009), while LD50 in rats of
aqueous and Ethanolic (EtOH) leaf extracts from Wp
P. indica were 12.30 g/kg and 6.15 g/kg, respectively
(Pramanik et al., 2007).
In this work, both Bc-Wp and Bc-Cc showed
a LD50 value of >2 g/kg when administered by
i.g. route in mice; thus, they are considered a
Category 5 substance according to the Organization
of Economic Co-operation and Development (OECD)
Test Guideline 423 for compounds whose possible
toxic or lethal effect in a single administration
is between >2,000 and <5,000 mg/kg by i.g.
route (Arthur et al., 2011). Nonetheless, further
toxicological studies are needed to ensure their safety.
It is noteworthy that LD50 value for main metabolite
Vb produced by Wp and cell suspension cultures of B.
cordata, was established in other studies as >5 g/kg in
mice via i.p. administration (Etemad et al., 2015).
To date, there are few studies that support the
safety of single administration of Buddleja species.
One of this evaluated acute toxicity of EtOH extract
from leaves and bark of wild B. asiatica Lour. in albino
mice of either sex at doses of 500, 1,000, and 2,000
mg/kg of each extract by i.g. route. The authors found
that, even at the highest dose, animal exhibited no
lethal or adverse effects (Ullah et al., 2014). However,
a greater number of subsequent toxicological studies
are required to ensure the use of these suspension cell
cultures obtained through biotechnology.
3.3 Anti-inflammatory and anti-arthritic
evaluation
3.3.1 TPA model
One of the main uses of aerial parts of Buddleja
species include aiding in wound healing (Jensen,
2000). In Mexican folk medicine, these aerial parts
are also used to treated diseases and inflammations
related to skin (Acevedo et al., 2000). Bc-Cc extract
showed an important beneficial effect when applied
topically that was dose-dependent. For 2-mg/ear
dose, a value of 61.72% inhibition on ear-edema
development was observed, statistically similar to that
generated by Indomethacin at same dose (57.35%).
However, the anti-inflammatory activity of Bc-Wp
extract at same dose was lower (26.10%) than the
effect of Indomethacin (58.25%), and it was not dose-
dependent because all of the tested doses of this extract
generated a similar statistical effect on ear-edema
growth (Table 1). ED50 values for Bc-Cc and Bc-Wp
were 1.26 and 3.93 mg/ear, respectively, while for
Indomethacin in both experiments, ED50 was ≈1.47
mg/ear for a single topical administration in both
experiments (Table 1).
These results are better than data reported for
B. globosa aerial parts MeOH extract evaluated for
TPA model, the anti-inflammatory effect was 56.7 %
inhibition at 3 mg/ear (Backhouse et al., 2008). Also,
main metabolite Vb, has been evaluated previously
in mice TPA model, being isolated from ethyl
acetate extract of Castilleja tenuiflora. Subsequently,
it generated 49% inhibition on ear edema formation at
1.6 mg/ear dose (Sa´nchez et al., 2013), authors said
that this effect was through the inhibition of important
biochemical pathways such as Nuclear Factor-kappa B
(NF-κB) expression. Compared to the results obtained
in present work, only Bc-Cc MeOH extract exhibited
a similar effect to that of C. tenuiflora-isolated
Vb at a similar dose. From minor SM previously
identified in B. cordata (Estrada-Zu´n˜iga et al., 2009),
linarin has shown to down-regulate the production of
pro-inflammatory cytokines such as Tumor Necrosis
Factor alpha (TNF-α), Interleukin (IL)-1β, and IL-
6, as well as the release of Nitric Oxide (NO), all
of which are involved in acute inflammation process
(Kim et al., 2016b), related to the mechanism of action
through which TPA generate edema formation.
3.3.2 Carrageenan model
In this experiment Bc-Cc generated a dose-
dependent anti-inflammatory effect on paw-edema
formation, with best response at dose of 200 mg/kg
(48.87%), with no statistical differences compared
to Indomethacin (54.11%). At hour 5 of the model,
the same dose-dependent behavior was observed for
Bc-Wp, however, this showed less anti-inflammatory
activity compared to Bc-Cc, its major activity
observed at 200 mg/kg dose (39.80%), nonetheless,
this was lower than the inhibition achieved by
Indomethacin (50.01%) (Table 2). ED50 values for
Bc-Cc and Bc-Wp were 204.62 and 251.26 mg/kg,
respectively, for hour 5 (Table 2). These results
indicated that a lesser quantity of Bc-Cc extract
generated better anti-inflammatory activity than Bc-
Wp with an inhibition nearly to 50% over paw-edema
development.
Backhouse et al. (2008), demonstrated that MeOH
fraction obtained from MeOH extract of aerial parts
from B. globosa Wp generated an inhibition of
61.40% on edema formation in third hour after its
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Table 1. Anti-inflammatory effect of MeOH extract of leaves from Buddleja cordata Wild plant (Bc-Wp) and its
Cell suspension culture (Bc-Cc) on the development of ear edema induced by TPA (mg).
 
Manuscrito sometido a la Revista Mexicana de Ingeniería Química                  1 
 
Table 1.  1 
 2 
Treatments 1 Doses 
(mg/ear) 
Auricular edema 
formation (mg) 
Inhibition 
percent (%) 
ED50 
(mg/ear) 
TPA Control - 16.88±0.76 - - 
 
Indomethacin 
0.5 12.65±0.32a 25.05  
1.47 (R2 = 0.99) 1 10.54±0.45•a 37.56 
2 7.20±0.68•*a 57.35 
 
Bc-Cc 
MeOH extract 
0.5 13.04±0.33a 22.15  
1.26 (R2 = 0.98) 1 9.00±0.76•ab 46.68 
2 6.46±0.38•*ab 61.72 
 
Treatments 2 
  
TPA Control - 23.30±0.56 - - 
 
Indomethacin 
0.5 16.93±0.32a 27.03  
1.48 (R2 = 0.99) 1 14.06±0.34•a 39.41 
2 9.69±0.60•*a 58.25 
 
Bc-Wp 
MeOH extract 
0.5 17.87±0.56a 22.90  
3.93 (R2 = 0.95) 1 17.29±0.67ab 25.49 
2 17.14±0.42ab 26.10 
 3 
 4 
 5 
 6 
Table 2.  7 
 8 
 9 
Treatments 1 Doses (mg/kg) 
Paw edema formation 
(mm) T5h 
Inhibition percent 
(%) 
ED50 
(mg/kg) 
Carrageenan Control  - 1.10±0.05 - - 
Indomethacin 10 0.50±0.01a 54.11 10 
Bc-Cc  
MeOH extract 
10 1.00±0.01ab 9.09 
204.62 
(R2 = 0.98) 
25 0.92±0.01abc 16.36 
50 0.69±0.06 abcd 29.67 
100 0.75±0.05abcd 23.76 
200 0.56±0.02 abcdef 48.87 
Treatments 2     
Carrageenan Control - 1.00±0.05 - - 
Indomethacin 10 0.50±0.01a 50.01 10 
Bc-Wp  
MeOH extract 
10 0.91±0.02ab 9.00  
 
251.26 
(R2 = 0.97) 
 
25 0.77±0.02ab 17.63 
50 0.72±0.01abc 21.00 
100 0.73±0.01abc 20.16 
200 0.61±0.01abcdef 39.80 
 10 
 11 
Data presented as mean (±) standard error (s.e.). The percent of inhibition edema is with respect to control group. Statistical
analysis two ways ANOVA, post hoc SNK tests (p ≤ 0.05). Each treatment (1 and 2) were carried out in independent experiments
Treatments 1: · vs 0.5 mg; * vs 1 mg; a vs TPA control; b vs Indomethacin Treatments 2: · vs 0.5 mg; * vs 1 mg; a vs TPA control; b
vs Indomethacin Bc-Cc, Cell suspension culture MeOH extract of Buddleja cordata Bc-Wp, Buddleja cordata Wild plant MeOH
extract n = 7 per group.
Table 2. Anti-inflammatory effect of MeOH extract of leaves from Buddleja cordata Wild plant (Bc-Wp) and its
Cell suspension culture (Bc-Cc) on the development of Carrageenan-induced acute inflammation (mm).
 
Manuscrito sometido a la Revista Mexicana de Ingeniería Química                  1 
 
Table 1.  1 
 2 
Treatments 1 Doses 
(mg/ear) 
Auricular edema 
formation (mg) 
Inhibition 
percent (%) 
ED50 
(mg/ear) 
TPA Control - 16.88±0.76 - - 
 
Indomethacin 
0.5 12.65±0.32a 25.05  
1.47 (R2 = 0.99) 1 10.54±0.45•a 37.56 
2 7.20±0.68•*a 57.35 
 
Bc-Cc 
MeOH extract 
0.5 13.04±0.33a 22.15  
1.26 (R2 = 0.98) 1 9.00±0.76•ab 46.68 
2 6.46±0.38•*ab 61.72 
 
Treatments 2 
  
TPA Control - 23.30±0.56 - - 
 
Indomethacin 
0.5 16.93±0.32a 27.03  
1.48 (R2 = 0.99) 1 14.06±0.34•a 39.41 
2 9.69±0.60•*a 58.25 
 
Bc-Wp 
MeOH extract 
0.5 17.87±0.56a 22.90  
3.93 (R2 = 0.95) 1 17.29±0.67ab 25.49 
2 17.14±0.42ab 26.10 
 3 
 4 
 5 
 6 
Table 2.  7 
 8 
 9 
Treatments 1 Doses (mg/kg) 
Paw edema formation 
(mm) T5h 
Inhibition percent 
(%) 
ED50 
(mg/kg) 
Carrageenan Control  - 1.10±0.05 - - 
Indomethacin 10 0.50±0.01a 54.11 10 
Bc-Cc  
MeOH extract 
10 1.00±0.01ab 9.09 
204.62 
(R2 = 0.98) 
25 0.92±0.01abc 16.36 
50 0.69±0.06 abcd 29.67 
100 0.75±0.05abcd 23.76 
200 0.56±0.02 abcdef 48.87 
Treatments 2     
Carrageenan Control - 1.00±0.05 - - 
Indomethacin 10 0.50±0.01a 50.01 10 
Bc-Wp  
MeOH extract 
10 0.91±0.02ab 9.00  
 
251.26 
(R2 = 0.97) 
 
25 0.77±0.02ab 17.63 
50 0.72±0.01abc 21.00 
100 0.73±0.01abc 20.16 
200 0.61±0.01abcdef 39.80 
 10 
 11 
Each group represents the mean (±) and standard error (s.e.). The application was by intragastric route. Statistical analysis two-
way ANOVA, post hoc SNK test (p≤0.05). Each treatment (1 and 2) were carried out in independent experiments Treatments
1: a vs Carrageenan control. b vs Indomethacin. c vs Cc 10 mg/kg. d vs Cc 25 mg/kg. e vs Cc 50 mg/kg. f vs Cc 100 mg/kg
Treatments 2: a vs Carrageenan control. b vs Indomethacin. c vs Cp 10 mg/kg. d vs Cp 25 mg/kg. e vs Cp 50 mg/kg. f vs Cp 100
mg/kg NE, no effect Bc-Cc, Cell suspensi n culture MeOH extract of Buddleja cordata Bc-Wp, B ddlej cordata Wild plant
MeOH extract n=7 per group.
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i.g. administration at dose of 600 mg/kg in Guinea
pigs. Later, Bukhari et al. (2016), showed that, in
hour 3 after i.p. administration of aqueous-MeOH
extract from whole wild plant of B. crispa, paw-
edema growth was inhibited by 65% at 200 mg/kg
dose in rats. Finally, Al-Ati et al. (2015) found
that aqueous fraction obtained from EtOH extract
from Wp B. polystachya aerial parts inhibited paw
edema formation by 60.70% in second hour after i.p.
administration at 500 mg/kg dose in rats. Compared
to the results reported by Bukhari et al. (2008),
and Al-Ati et al. (2015), the anti-inflammatory effect
generated by those tested extracts in Carrageenan
murine model was lower than that of MeOH extract
from Bc-Wp aerial parts (39.80%) at a 200 mg/kg
dose, perhaps due to differences between plant species
and their phytochemical profiles.
To explain through which possible mechanisms
this systemic anti-inflammatory effect is taking place,
we think is due to Vb because this major metabolite
of B. cordata by itself generated inhibition in paw
edema development of 21.50 and 27% at hours
4.5 and 6, respectively, after its administration by
i.g. route in rats at 200 mg/kg (Akdemir et al.,
2011). Also by linarin, a minor SM identified in
B. cordata, which demonstrated in previous work
an anti-inflammatory effect in Carrageenan model in
mice with an ED50 value of 0.6 mg/kg administered
i.g. The authors describe and establish that this
beneficial effect is due to inhibition of inflammation-
induced cyclooxygenase (COX-2), and arachidonic
acid (AA) pathway (Martı´nez-Va´zquez et al., 1998),
both related to the paw edema-induction mechanism
of Carrageenan.
3.3.3 CFA-induced arthritis model
Un-treated arthritic mice generated a maximal edema
diameter of 1.59 ± 0.09 mm on day 15 (after CFA
reinjection on day 14) and 1.38 ± 0.03 mm on day
28, compared to healthy animals which only received
vehicle and that did not receive sub-plantar injection
of CFA. This reinjection was performed in order to
maintain the chronic inflammatory condition for a
period of 28 days, while all the groups that received
the treatments showed the following day (day 15) a
percentage of inhibition of ≈16% compared to arthritic
untreated group of animals, after being administered
for two weeks since day 7.
This group was used as experimental arthritis
control to determine the beneficial effect of
treatments (PBZ, Bc-Cc and Bc-Wp MeOH extracts).
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Fig. 2. Anti-inflammatory effect of MeOH extracts
from Wild plant B. cordata leaves (Bc-Wp) and its Cell
culture (Bc-Cc) on paw-edema development in male
BALB/C mice during experimental arthritis. Data
shown as mean ± Standard Error of the Mean (SEM).
Treatments were administered daily by intragastric
(i.g.) route from day 7 to day 28. Two-way ANalysis
Of VAriance (ANOVA) of Repeated Measures (RM),
post-hoc Student-Newman-Keuls (SNK), (p ≤ 0.05)
a vs. VEHicles (VEH); b vs. CFA control; c vs.
CFA+PBZ; d vs. CFA+MeOH Bc-Wp 250 mg/kg ·vs.
day 7; *vs. day 14; vs. day 15; vs. day 21 CFA:
Complete Freund’s Adjuvant PBZ: PhenylButaZone
Bc-Wp, Buddleja cordata Wild plant Bc-Cc, Cell
suspension culture Buddleja cordata n= 7 per group.
Statistical analysis revealed that all three
treatments generated moderate anti-arthritic effect
on induced mice compared to the untreated arthritic
group; however, there were no statistical differences
between them. In this context, PBZ-administered
mice showed inhibition in paw edema development of
38.42% at day 28, while Bc-Cc and Bc-Wp exhibited
inhibition values of 30.26 and 35.46%, respectively,
compared to un-treated CFA-induced group on day
28 (Fig. 2). None of the treatments were statistically
similar to data shown by healthy animals at the end of
the experiment.
CFA-induced experimental arthritis was
previously described for mice, where authors
sustained that edema development was related to
an increase in neutrophils and lymphocyte CD4++
infiltration, and to increased production of pro-
inflammatory mediators (TNF-α, IL-1β, IL-6, and
interferon gamma [INF-γ]) (Rasool et al., 2006).
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Fig. 3. Effect of MeOH extracts from Wild plant
B. cordata leaves (Bc-Wp) and its Cell suspension
culture (Bc-Cc) on body weight gain in male BALB/C
mice during experimental arthritis. Data shown
as mean ± Standard Error of the Mean (SEM).
Treatments were administered daily by intragastric
(i.g.) route from day 7 to day 28. Two-way ANalysis
Of VAriance (ANOVA) of Repeated Measures (RM),
post-hoc Student-Newman-Keuls (SNK), (p ≤ 0.05)
a vs. VEHicles (VEH); b vs. CFA control; c vs.
CFA+PBZ; d vs. CFA+MeOH Bc-Wp 250 mg/kg ·vs.
day 7; *vs. day 14; vs. day 15; vs. day 21 CFA:
Complete Freund’s Adjuvant PBZ: PhenylButaZone
Bc-Wp, Buddleja cordata Wild plant Bc-Cc, Cell
suspension culture Buddleja cordata n= 7 per group.
Beneficial effect generated by both MeOH extracts
prepared from Wp (Bc-Wp) and cell suspension
cultures (Bc-Cc) of B. cordata may be due to their
content of their main phenylpropanoid Vb. In an early
work, Lenoir et al. (2011), found that aqueous extract
of leaves from Aloysia triphylla (Lemon verbena)
with a high content of Vb generated a decrease of
chronic inflammation damage in a model of dextran
sulfate sodium-induced colitis in Wistar rats at a
dose of 5% of extract in their drinking water. It also
reduced oxidative damage and favored regulation of
antioxidant enzymes activity in intestinal tissue.
Another parameter that was measured during
experimental arthritis was BW gain for each group,
the differences between total weights of each day
were compared to baseline weight before CFA paw
injection. Results exhibited that un-treated arthritic
mice showed lower BW gain (1.29 g) compared
to that of the healthy group (3.88 g) at day 28.
 
 
Fig. 4. Effect of MeOH extracts from Wild plant
B. cordata leaves (Bc-Wp) and its Cell suspension
culture (Bc-Cc) on relative weight of edema tissue
of male BALB/C mice during experimental arthritis.
Data shown as mean ± Standard Error of the Mean
(SEM). Values in parentheses showed relative weight
of each tissue related to the total animal body weight
on day 28 of the experiment. ANOVA on ranks, Post-
hoc SNK (p ≤ 0.05) a vs Vehicles (VEH); bvs. CFA
control; cvs. CFA+PBZ; dvs. CFA+ MeOH Bc-Wp
250 mg/kg CFA: Complete Freund’s Adjuvant PBZ:
PhenylButaZone Bc-Wp, Buddleja cordata Wild plant
Bc-Cc, Cell suspension culture Buddleja cordata n =
7 per group.
All treatments (Bc-Cc, PBZ, and Bc-Wp)
generated a statistical increase in BW gain of 121.71,
110.08, and 55.04%, respectively, in arthritic-treated
mice compared to un-treated arthritic group; however,
none of them reach similar values to those of the
BW gain of healthy animals at day 28 (Fig. 3). It
was previously described that an increment of pro-
inflammatory cytokines such as TNF-α could act
as an inhibitor of the neuropeptide Y/leptin axis,
decreasing food intake and modifying BW gain during
experimental arthritis (Gonza´lez-Hita et al., 2006) as
well as, in this assay the animals cannot move because
of the severe inflammation they develop.
At the end of experimental arthritis, relative weight
of sub-plantar edema and popliteal ganglion tissues
were calculated related to total weight of each mouse
on day 28. Edema tissue of arthritic un-treated mice
showed an increase of 1.84% compared to sub-plantar
tissue from healthy animals (0.4%); however, arthritic
mice treated with PBZ, or Bc-Wp, or Bc-Cc showed
values of 0.78, 0.93, and 0.88%, respectively, with
no statistical differences between them. Nonetheless,
all of them generated a statistical decrease
compared to the CFA un-treated group (Fig. 4).
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Fig. 5. Effect of MeOH extracts from Wild plant
B. cordata leaves (Bc-Wp) and its Cell suspension
culture (Bc-Cc) on relative weight of popliteal
ganglion of male BALB/C mice during experimental
arthritis. Data shown as mean ± Standard Error of the
Mean (SEM). Values in parentheses showed relative
weight of each tissue related to the total animal body
weight on day 28 of the experiment. ANOVA on anks,
Post-hoc SNK (p ≤ 0.05) avs. VEHicles (VEH); bvs.
CFA control; cvs. CFA+PBZ; dvs. CFA+ MeOH Bc-
Wp 250 mg/kg CFA: Complete Freund’s Adjuvant
PBZ: PhenylButaZone Bc-Wp, Buddleja cordata Wild
plant Bc-Cc, Cell suspension culture Buddleja cordata
n = 7 per group.
Finally, results for popliteal ganglion relative
weight showed same behavior as those of sub-plantar
edema, in which an increase was observed for un-
treated arthritic mice (0.21%) compared to healthy
group values (0.06 %); all other groups exhibited a
statistical decrease of popliteal ganglion size (12%)
in comparison to CFA un-treated group (Fig. 5).
An increase in many organs or tissues size during
experimental arthritis, such as popliteal ganglion or
sub-plantar edema, is due to an increase of leukocyte
infiltration and high production of pro-inflammatory
mediators (Pesce et al., 2015). As in the acute toxicity
model, no abnormal growth was observed in any of
the organs extracted on day 28 of the study, mainly the
spleen.
Reduction of follicular hyperplasia in ganglionic
tissue observed in arthritic mice treated with Bc-Wp
and Bc-Cc may be due to its main metabolite, Vb,
which is a potent inhibitor of NF-kB pathway, related
to leukocyte infiltration, prostaglandin bio-synthesis,
and edema formation in tissues (Pesce et al., 2015).
Finally, Kim et al. (2016a), described beneficial effect
of Chrysanthemum zawadskii var. Latilobum EtOH
extract in collagen-induced experimental arthritis in
mice. These authors mentioned that this anti-arthritic
activity may be due to the high linarin content
found in the extract, being this compound one of the
SM identified in both MeOH extracts of Buddleja
cordata, but it compounds was not quantified in this
work. Despite all the previously described results for
this CFA-induced experimental arthritis model, more
specific molecular biology tests are required as well
as a greater number of doses tested, being this a first
preliminary study through which the behavior of both
MeOH extracts was observed using the ED50 obtained
from the acute inflammation model of carrageenan-
induced paw edema. Today the identification and
quantification of this compound (linarin) is in process,
for order to determine their concentration in both
extracts (Bc-Cc and Bc-Wp).
Conclusions
Results showed that Wp Buddleja cordata (Bc-Wp)
produces small quantities of polyphenols such as
verbascoside and the in vitro cultures (Bc-Cc) of this
plant bio-synthesize more Vb compared to Wp leaves
and has high purity rate, and that this could be related
to their anti-inflammatory effect in acute and chronic
phase. Certainly, anti-inflammatory activity shown by
MeOH extract of B. cordata cell culture (Bc-Cc) is
similar to that reported for Vb per se, and allopathic
reference drugs, highlighting the potential of cell
suspension cultures for producing anti-inflammatory
agents from medicinal plants tissue samples.
Nomenclature
AA arachidonic acid
ANOVA analysis of variance
Bc-Cc Buddleja cordata cell suspension culture
Bc-Wp Buddleja cordata wild plant
BW body weight gain, g / body weight for
doses, g or mg kg−1
CFA Complete Freund’s Adjuvant
COX-2 inflammation-induced cyclooxygenase
DW dry weight of extract and secondary
metabolites, mg g−1
ED50 median effective dose, g or mg kg−1
EtOH ethanol
GAE gallic acid equivalents, mg GAE g−1 DW of
extract
HPLC High-Performance Liquid Chromatography
i.g. intragastric
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IL interleukin
INF-γ interferon gamma
i.p. intraperitoneal
LD50 median lethal dose, mg or g kg−1
MeOH methanol
NF-κB, nuclear factor-kappa B
NO nitric oxide
PBZ phenylbutazone
QE quercetin equivalents, µg QE g−1 DW of
extract
Rt retention time
SEM standard error of the mean
SM secondary metabolites
SNK Student-Newman-Keuls
TFC total flavonoid content
TNF-α tumor necrosis factor alpha
TPA 12-O-tetradecanoylphorbol-13-acetate
TPC total phenolic content
v/v volume/volume
Vb verbascoside
Wp wild plant
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